Updated Use Instructions for Maquet Servo Ventilator Systems

Risk in Neonatal Tidal Volume Delivery
Servo ventilation systems

Maquet Servo Ventilator Systems
Source: FDA

Urgent Class I Medical Device Correction

Maquet Critical Care AB, a subsidiary of Getinge, has issued an urgent correction notice regarding its Servo Ventilator Systems (Servo-u, Servo-n, and Servo-u MR). This correction does not involve product removal, but the FDA has classified it as a Class I recall, the most serious type, due to the potential risk of injury or death if devices are used incorrectly.

Device Overview

These ventilators are used in professional healthcare settings for neonatal, pediatric, and adult patients, including in MR environments (Servo-u MR only). The devices assist or control breathing by delivering oxygen-rich air at controlled volumes.

Issue Summary

Maquet has updated its user instructions after discovering that incorrect configuration of the “Extended leakage test” could cause inaccurate compliance measurements, especially dangerous for neonatal patients. This could result in improper tidal volume delivery:

  • In PRVC mode, up to 50% less tidal volume may be delivered than displayed.
  • In Pressure Control mode, displayed tidal volume may appear higher than what is delivered.

Health Risks

Improper tidal volume delivery may cause hypoventilation, hypoxia, or hypercapnia, particularly in extremely premature neonates. One injury has been reported, with no deaths to date.

Recommended Actions

Issued on May 30, 2025, the correction letter advises:

  • Set the “Extended leakage test” to OFF unless using a compatible humidifier (see User Manual, Chapter 8.2.4).
  • Follow revised safety check instructions in Appendix 1, Chapter 9.5.1 of the user’s manual.
  • Notify all affected personnel and verify all ventilators are properly configured.

Contact Info

For technical assistance, U.S. customers can reach Maquet Technical Services at 1-888-943-8872 (Option 4), weekdays 8:00 a.m. to 6:00 p.m. ET.

Read the original medical device alert here.

QMSR Clause 8 – Measurement Analysis and Improvement

ISO 13485 Clause 8 Transition Notes  The QMSR eliminates FDA-specific structure in favor of ISO 13485:2016 clauses. All above ISO 13485 clauses are now explicit requirements under QMSR.  New documentation and risk-based decision-making are emphasized throughout the...

QMSR Clause 7 – Product Realization

ISO 13485 Clause 7 - Product Realization  Clause 7 of ISO 13485, titled Product Realization, outlines the structured approach medical device manufacturers must take to design, develop, produce, and deliver devices that meet customer needs and regulatory requirements....